BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Pharm Country

  Price of Teva’s Generic Drug to Treat Wilson’s Disease Sparks Outrage

  Patients are discovering that Teva’s generic isn’t really that much cheaper than Valeant Pharmaceutical’s branded drug to treat Wilson’s Disease.

  February 26, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Shares Plunge as ARCA biopharma’s Gencaro Had Mixed Phase II Clinical Trial Results

  ARCA biopharma announced positive headline results from its Phase IIb clinical trial of Gencaro, but investors aren’t buying the positive spin.

  February 26, 2018

   · 

  3 min read

   · 

  Mark Terry
• Business

  MD Anderson and RaySearch announce strategic alliance to advance radiation therapy of cancer

  The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy.

  February 26, 2018

   · 

  4 min read
• 

  FDA

  FDA Grants Yisheng Biopharma’s Clinical Treatment its Second Orphan Drug Designation

  Beijing-based Yisheng Biopharma Co. is celebrating this morning after its lead immunology treatment snagged a second Orphan Drug Designation from the U.S. Food and Drug Administration.

  February 26, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  U.K. Could Seek Restitution from Pfizer if Legal Appeal Fails

  Pfizer is fighting to preserve Lyrica’s use as the preferred physician’s treatment for nerve pain in the U.K.

  February 26, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  European Regulators Make Decisions on Several Companies’ Drugs

  The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) announced a string of approvals, as well as a couple rejections.

  February 26, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Vertex Pharmaceuticals Appoints Reshma Kewalramani as New CMO

  Vertex Pharmaceuticals announced that Reshma Kewalramani will be the new chief medical officer and executive vice president, Global Medicines Development and Medical Affairs

  February 26, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Diabetes Market Heats Up as Eli Lilly’s Trulicity Combo Shows Improved Blood Sugar Control

  Eli Lilly and Company published results from a new Phase IIIb clinical trial of Trulicity (dulaglutide) in combination with a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, which has shown improved blood sugar control in adults with type 2 diabetes.

  February 26, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  ObsEva Fertility Drug Shows Some Promise in Late-Stage Trial

  ObsEva Sa highlighted a data point from a late-stage trial that showed its fertility treatment nolasiban was successful in improving the pregnancy rate of some women following in vitro fertilization.

  February 26, 2018

   · 

  2 min read

   · 

  Alex Keown
• Business

  Henrik Stenqvist is Joining Sobi as New Chief Financial Officer

  Henrik Stenqvist will be appointed Chief Financial Officer (CFO) and will join Sobi in late spring

  February 26, 2018

   · 

  2 min read